-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
June 09, 2020 - Acupuncture
suppresses reinstatement of morphine-seeking
behavior induced by a complex cue in rats.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/draft-report-plant-based-treatment.pdf
March 01, 2021 - 16.88).50 The reduction in dose was
small, but statistically significant (MD −0.64 mg intravenous morphine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
February 01, 2013 - Postoperative pain NCT01204606: intraoperative periarticular
management injection (ropivacaine, morphine
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
November 01, 2017 - Levorphanol”[mh] OR “Meperidine”[mh] OR “Meptazinol”[mh] OR
“Methadone”[mh] OR “Methadyl Acetate”[mh] OR “Morphine
-
www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
November 01, 2017 - Levorphanol”[mh] OR “Meperidine”[mh] OR “Meptazinol”[mh] OR
“Methadone”[mh] OR “Methadyl Acetate”[mh] OR “Morphine
-
preventiveservices.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
November 01, 2017 - Levorphanol”[mh] OR “Meperidine”[mh] OR “Meptazinol”[mh] OR
“Methadone”[mh] OR “Methadyl Acetate”[mh] OR “Morphine
-
preventiveservices.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
November 01, 2017 - Levorphanol”[mh] OR “Meperidine”[mh] OR “Meptazinol”[mh] OR
“Methadone”[mh] OR “Methadyl Acetate”[mh] OR “Morphine
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
November 01, 2017 - Levorphanol”[mh] OR “Meperidine”[mh] OR “Meptazinol”[mh] OR
“Methadone”[mh] OR “Methadyl Acetate”[mh] OR “Morphine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bivariate-methods-utility_research.pdf
November 01, 2012 - Efficacy of morphine sulfate-augmented
hepatobiliary imaging in acute cholecystitis.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - major psychiatric disorder or past drug/alcohol abuse excluded Opioids maximal dose
below 40 mg/day of morphine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - major psychiatric disorder or past drug/alcohol abuse excluded Opioids maximal dose
below 40 mg/day of morphine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - major psychiatric disorder or past drug/alcohol abuse excluded Opioids maximal dose
below 40 mg/day of morphine
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-e-evidence-tables.xlsx
March 25, 2024 - major psychiatric disorder or past drug/alcohol abuse excluded Opioids maximal dose
below 40 mg/day of morphine
-
datatools.ahrq.gov/meps-hc/?type=tab&tab=mepshcpd
January 01, 2015 - Statistics on total expenditures, total purchases, and number of persons with purchases for prescription medicines or therapeutic class groups.Select the Download Data button for an accessible MS Excel version of the data visualization. The file size will depend on parameters selected.Notes: Prescribed Drug …